ArticleEuropean journal of nuclear medicine and molecular imaging2021
The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community.
Article in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Health system patterns of imaging and fluid biomarker testing in the era of anti-amyloid therapies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- The Status of Neuroimaging with SPECT and PET in Germany: Results from the 1st Survey on Nuclear Neuroimaging in Germany in 2023.Nuklearmedizin. Nuclear medicine · 2025Article
- Capacity for brain amyloid PET in Germany: Results from the 1st survey on nuclear brain imaging in Germany.European journal of nuclear medicine and molecular imaging · 2025Article
- Autoradiographic comparison between [EJNMMI research · 2025Article
- FDA approval of lecanemab: the real start of widespread amyloid PET use? - the EANM Neuroimaging Committee perspective.European journal of nuclear medicine and molecular imaging · 2023Article
- Application ofEuropean journal of nuclear medicine and molecular imaging · 2023Article
- A comparison of advanced semi-quantitative amyloid PET analysis methods.European journal of nuclear medicine and molecular imaging · 2022Article
- AdvancingTheranostics · 2022Article
- Amyloid beta plaque accumulation with longitudinal [18F]AZD4694 PET.Alzheimer's & dementia (Amsterdam, Netherlands)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
34272989What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.